Skip to content
ProvidersDesk
Q5136

Inj. denosumab-bbdz, 1 mg

✓ CURRENT — JULY 2026
Source: CMS
Imported: Aug 10 2026

Full descriptor

Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg

Details

Code
Q5136
Short descriptor
Inj. denosumab-bbdz, 1 mg
Code set
HCPCS Level II
Release
July 2026
Status
Active
Added
Oct 1 2024

Nearby codes

Code sets are published in blocks, so neighbours are usually related.

Q5135

Inj, tyenne, 1 mg

Q5137

Inj, wezlana, sub cu, 1 mg

Q5134

Inj, tyruko, 1 mg

Q5138

Inj, wezlana, iv, 1 mg

Q5133

Inj, tofidence, 1 mg

Q5140

Inj adalimumab-fkjp, 1 mg

Q5141

Inj adalimumab-aaty, 1 mg

Q5130

Inj, fylnetra, 0.5 mg

Sources

Reference information only. Not billing advice. Verify against the payer before you file.